FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2904420984> ?p ?o ?g. }

• W2904420984 abstract "Background: The biological diagnostics of APS takes into account the persistent positivity for anticardiolipin and/or anti-β2GP1 antibodies and/or presence of lupus anticoagulant (LA). However, some new non-conventional antiphospholipid antibodies have emerged that could help in the diagnosis of APS. Objectives: To study the potential usefulness of non-conventional antiphospholipid antibodies in clinical practice. Methods: 87 patients, aged from 15 to 92 years were included and classified in following groups: 41 patients. positive for the conventional antibodies with clinical criterion of APS (31 with primary APS and 10 secondary), 17 seronegative APS patients (i.e. persistent negativity for the conventional antibodies with a strong clinical suspicion of APS), 11 asymptomatic antiphospholipid antibodies carriers (i.e. persistent positivity for the conventional antibodies without clinical evidence of APS), and 18 patients presenting with a first thrombotic or obstetrical event). IgG and IgM were detected to the following antigens: phosphatidylserine/prothrombin (PS/PT) by ELISA, and phosphatidic acid, phosphatidyl-ethanolamine, phosphatidyl-glycerol, phosphatidyl-inositol, phosphatidylserine, annexin V, prothrombin, cardiolipin and β2GP1 by immunodot. Anti-2GP1 IgA and anti-2GP1domain I IgG were detected by chemiluminescence. Results:. Positivity for the non-conventional antibodies was correlated with APS severity; patients with CAPS being positive for 10.7 (Median, Range: 5-14) non-conventional antibodies. 9/17 seronegative patients were positive for at least one of non-conventional antibodies. A study of non-supervised hierarchical clustering of all markers revealed that anti-PS/PT antibodies showed high correlation with the presence of LA. All patients with APS triple positivity (highest risk profile) exhibited also persistent positivity for anti-PS/PT antibodies. Conclusions: Our findings suggest that non-conventional APS antibodies could be useful for patients classified as seronegative APS. Furthermore, anti-PS/PT antibodies could be a surrogate APS biological marker of LA to classify in high-risk profile patients treated by direct oral anticoagulants, in whom LA detection cannot be achieved." @default.
• W2904420984 created "2018-12-22" @default.
• W2904420984 creator A5000237074 @default.
• W2904420984 creator A5031941526 @default.
• W2904420984 creator A5037436313 @default.
• W2904420984 creator A5053292654 @default.
• W2904420984 creator A5076339052 @default.
• W2904420984 creator A5078831201 @default.
• W2904420984 date "2018-12-14" @default.
• W2904420984 modified "2023-10-15" @default.
• W2904420984 title "Prevalence and Significance of Non-conventional Antiphospholipid Antibodies in Patients With Clinical APS Criteria" @default.
• W2904420984 cites W1820213619 @default.
• W2904420984 cites W1930926314 @default.
• W2904420984 cites W1940591286 @default.
• W2904420984 cites W1963872077 @default.
• W2904420984 cites W1975074770 @default.
• W2904420984 cites W1992631495 @default.
• W2904420984 cites W2013194989 @default.
• W2904420984 cites W2015878170 @default.
• W2904420984 cites W2020294005 @default.
• W2904420984 cites W2022864916 @default.
• W2904420984 cites W2036910363 @default.
• W2904420984 cites W2040532865 @default.
• W2904420984 cites W2041919675 @default.
• W2904420984 cites W2042958596 @default.
• W2904420984 cites W2054330426 @default.
• W2904420984 cites W2067533331 @default.
• W2904420984 cites W2069794594 @default.
• W2904420984 cites W2069797332 @default.
• W2904420984 cites W2081684310 @default.
• W2904420984 cites W2090109431 @default.
• W2904420984 cites W2091318160 @default.
• W2904420984 cites W2098261358 @default.
• W2904420984 cites W2105482507 @default.
• W2904420984 cites W2119266650 @default.
• W2904420984 cites W2127565509 @default.
• W2904420984 cites W2128494532 @default.
• W2904420984 cites W2132103149 @default.
• W2904420984 cites W2134553643 @default.
• W2904420984 cites W2142444723 @default.
• W2904420984 cites W2143086319 @default.
• W2904420984 cites W2170984819 @default.
• W2904420984 cites W2278093194 @default.
• W2904420984 cites W2295271763 @default.
• W2904420984 cites W2336533554 @default.
• W2904420984 cites W2440701858 @default.
• W2904420984 cites W2567538246 @default.
• W2904420984 cites W2611488218 @default.
• W2904420984 cites W2726871844 @default.
• W2904420984 cites W2737936804 @default.
• W2904420984 cites W2751133429 @default.
• W2904420984 cites W2801010100 @default.
• W2904420984 cites W4248923399 @default.
• W2904420984 doi "https://doi.org/10.3389/fimmu.2018.02971" @default.
• W2904420984 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6302212" @default.
• W2904420984 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30619328" @default.
• W2904420984 hasPublicationYear "2018" @default.
• W2904420984 type Work @default.
• W2904420984 sameAs 2904420984 @default.
• W2904420984 citedByCount "60" @default.
• W2904420984 countsByYear W29044209842019 @default.
• W2904420984 countsByYear W29044209842020 @default.
• W2904420984 countsByYear W29044209842021 @default.
• W2904420984 countsByYear W29044209842022 @default.
• W2904420984 countsByYear W29044209842023 @default.
• W2904420984 crossrefType "journal-article" @default.
• W2904420984 hasAuthorship W2904420984A5000237074 @default.
• W2904420984 hasAuthorship W2904420984A5031941526 @default.
• W2904420984 hasAuthorship W2904420984A5037436313 @default.
• W2904420984 hasAuthorship W2904420984A5053292654 @default.
• W2904420984 hasAuthorship W2904420984A5076339052 @default.
• W2904420984 hasAuthorship W2904420984A5078831201 @default.
• W2904420984 hasBestOaLocation W29044209841 @default.
• W2904420984 hasConcept C126322002 @default.
• W2904420984 hasConcept C159654299 @default.
• W2904420984 hasConcept C203014093 @default.
• W2904420984 hasConcept C2776874634 @default.
• W2904420984 hasConcept C2777910003 @default.
• W2904420984 hasConcept C2780022809 @default.
• W2904420984 hasConcept C45189115 @default.
• W2904420984 hasConcept C71924100 @default.
• W2904420984 hasConcept C90924648 @default.
• W2904420984 hasConceptScore W2904420984C126322002 @default.
• W2904420984 hasConceptScore W2904420984C159654299 @default.
• W2904420984 hasConceptScore W2904420984C203014093 @default.
• W2904420984 hasConceptScore W2904420984C2776874634 @default.
• W2904420984 hasConceptScore W2904420984C2777910003 @default.
• W2904420984 hasConceptScore W2904420984C2780022809 @default.
• W2904420984 hasConceptScore W2904420984C45189115 @default.
• W2904420984 hasConceptScore W2904420984C71924100 @default.
• W2904420984 hasConceptScore W2904420984C90924648 @default.
• W2904420984 hasLocation W29044209841 @default.
• W2904420984 hasLocation W29044209842 @default.
• W2904420984 hasLocation W29044209843 @default.
• W2904420984 hasLocation W29044209844 @default.
• W2904420984 hasOpenAccess W2904420984 @default.
• W2904420984 hasPrimaryLocation W29044209841 @default.
• W2904420984 hasRelatedWork W2029794473 @default.
• W2904420984 hasRelatedWork W2079160440 @default.
• W2904420984 hasRelatedWork W2097468114 @default.

• next